Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
Clinical trial NCT01156792 · COMPLETED
Trial details
- NCT number
- NCT01156792
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.